Comparing Copaxone vs Rebif
| Copaxone (glatiramer) | Rebif (interferon beta-1a) |
|
|---|
| Copaxone (glatiramer) | Rebif (interferon beta-1a) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Copaxone is a combination of four amino acids that may be given to treat relapsing forms of multiple sclerosis in adults. It has been shown to significantly reduce the number of relapses but may be... View more |
Prescription only
Rebif may be used to reduce the frequency of exacerbations of MS and delay the progression of the disease in adults. It is usually self-administered by SC injection three times per week and the most... View more |
Related suggestions |
|||||||||||||||
| More about Copaxone (glatiramer) | More about Rebif (interferon beta-1a) | ||||||||||||||||
| Ratings & Reviews | |||||||||||||||||
|
Copaxone has an average rating of 7.5 out of 10 from a total of 133 ratings on Drugs.com. 65% of reviewers reported a positive effect, while 17% reported a negative effect. |
Rebif has an average rating of 6.8 out of 10 from a total of 29 ratings on Drugs.com. 62% of reviewers reported a positive effect, while 24% reported a negative effect. |
||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||||||||||
View all Copaxone side effects |
View all Rebif side effects |
||||||||||||||||
| Drug Class | |||||||||||||||||
| Generic Availability | |||||||||||||||||
|
N/A |
|||||||||||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Copaxone prices |
View all Rebif prices |
||||||||||||||||
| Dosage Forms | |||||||||||||||||
|
|
||||||||||||||||
| Brand Names | |||||||||||||||||
| Other glatiramer brands include: Glatopa | Other interferon beta-1a brands include: Avonex, Avonex Pen, Avonex Prefilled Syringe, Rebif Rebidose | ||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||||||||||
|
1 hour |
3 hours |
||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | |||||||||||||||||
|
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | |||||||||||||||||
|
A total of 1 drugs are known to interact with Copaxone:
|
A total of 339 drugs are known to interact with Rebif:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
||||||||||||||||
| Disease Interactions | |||||||||||||||||
|
No known disease interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|||||||||||||||||
| First Approval Date | |||||||||||||||||
|
December 20, 1996 |
March 07, 2002 |
||||||||||||||||
| WADA Class View classifications | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| More Information | |||||||||||||||||
| Patient Resources | |||||||||||||||||
| Professional Resources | |||||||||||||||||
| Related Treatment Guide | |||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.